Eduardo L. Setti
Celera Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eduardo L. Setti.
Bioorganic & Medicinal Chemistry Letters | 2003
Eduardo L. Setti; Dana E. Davis; Tobee Chung; John McCarter
A novel series of 3,4-disubstituted azetidinones based inhibitors of the cysteine protease cathepsin K (Cat K) has been identified. Although not optimized, some of these compounds show at least 100-fold selectivity against other cathepsins. The use of cyclic moieties as P2 elements has proven to be crucial to achieve a high degree of selectivity.
Bioorganic & Medicinal Chemistry Letters | 1997
David P. Czajkowski; Andhe V. Narender Reddy; Eduardo L. Setti; Oludotun A. Phillips; Ronald G. Micetich; Chieko Kunugita; Samarendra N. Maiti
Abstract The synthesis and in vitro synergies of (6R)-6-(α-hydroxybenzyl)-2β-methoxyiminomethyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 4 ) and 2β-acyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 15 ) are described. Compound 15 showed good in vitro synergy in combination with piperacillin and ceftazidime against chromosomally mediated class I cephalosporinase producing organisms including TEM, SHV, and OXA-type enzymes producing microorganisms.
Chemistry of Heterocyclic Compounds | 1998
Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Chieko Kunugita; Akio Hyodo; Samarendra N. Maiti
Two monobactam derivatives, potassium 4α-methyl-(3E)-[(thien-2-yl)methylene]-2-azetidinone-1-sulfonate and its (3Z)-isomer, were prepared and evaluated for their β-lactamase inhibitory activities. These compounds were devoid of β-lactamase inhibitory activity.
Archive | 2000
Clifford M. Bryant; James T. Palmer; Robert M. Rydzewski; Eduardo L. Setti; Zong-Qiang Tian; Shankar Venkatraman; Dan-Xiong Wang
Journal of Medicinal Chemistry | 2005
James T. Palmer; Clifford Bryant; Dan-Xiong Wang; Dana E. Davis; Eduardo L. Setti; Robert M. Rydzewski; Shankar Venkatraman; Zong-Qiang Tian; Leland C. Ii Burrill; Rohan Mendonca; Eric Springman; John McCarter; Tobee Chung; Harry Cheung; James W. Janc; Mary E. McGrath; John R. Somoza; Philip Enriquez; Z. Walter Yu; Robert M. Strickley; Liang Liu; Michael C. Venuti; M. David Percival; Jean-Pierre Falgueyret; Peppi Prasit; Renata Oballa; Denis Riendeau; Robert N. Young; Gregg Wesolowski; Sevgi B. Rodan
Journal of Medicinal Chemistry | 2003
Joel Robichaud; Renata Oballa; Peppi Prasit; Jean-Pierre Falgueyret; M. David Percival; Gregg Wesolowski; Sevgi B. Rodan; Donald B. Kimmel; Colena Johnson; Cliff Bryant; Shankar Venkatraman; Eduardo L. Setti; Rohan Mendonca; James T. Palmer
Journal of Medicinal Chemistry | 2006
Sheldon N. Crane; W. Cameron Black; James T. Palmer; Dana E. Davis; Eduardo L. Setti; Joel Robichaud; Julie Paquet; Renata Oballa; Christopher I. Bayly; Daniel J. McKay; John R. Somoza; Natalie Chauret; Carmai Seto; John Scheigetz; Greg Wesolowski; Frédéric Massé; Sylvie Desmarais; Marc Ouellet
Archive | 1997
Samarendra N. Maiti; Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji
Archive | 1998
Samarendra N. Maiti; Eduardo L. Setti; Oludotun A. Phillips; Andhe V. Narender Reddy; Ronald G. Micetich; Rajeshwar Singh; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji
Bioorganic & Medicinal Chemistry Letters | 2006
Eduardo L. Setti; Shankar Venkatraman; James T. Palmer; Xiaoming Xie; Harry Cheung; Walter Yu; Gregg Wesolowski; Joel Robichaud